TerrAscend TSNDF
OTC TSNDF
$0.61 +0.05 (+8.56%)
At close: Aug 19, 2026 · 3:19 PM UTC

TerrAscend (TSNDF) Notes Payables (2024 - 2026)

TerrAscend (TSNDF) posted quarterly Notes Payables of $56000.0 for Q1 2026, down 39.78% year-over-year from $93000.0 in Q1 2025, and down 94.21% quarter-over-quarter from $967000.0 in Q4 2025.

TerrAscend (TSNDF) Notes Payables (2024 - 2026) Analysis & Trends

TerrAscend (TSNDF) has reported Notes Payables for 3 consecutive years, with $56000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Notes Payables fell 39.78% year-over-year to $56000.0; the TTM figure through Mar 2026 stood at $56000.0 (down 39.78% YoY), while the FY2025 annual figure was $967000.0, up 951.09% from the prior year.
  • Notes Payables retreated to $56000.0 in Q1 2026 per TSNDF's latest filing, from $967000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $9.1 million in Q1 2024 and bottomed at $56000.0 in Q1 2026.
  • Historically, Notes Payables has averaged $2.0 million across 3 years, with a median of $756000.0 in 2024.
  • On a YoY basis, Notes Payables climbed as much as 951.09% in 2025 and fell as far as 98.98% in 2025.
  • TerrAscend's Notes Payables stood at $92000.0 in 2024, then jumped by 951.09% to $967000.0 in 2025, then plunged by 94.21% to $56000.0 in 2026.
  • Business Quant data shows TSNDF's Notes Payables at $56000.0 in Q1 2026, $967000.0 in Q4 2025, and $893000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 TerrAscend 187.35 Mn 145.23 Mn 36.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56,000.00
Dec 31, 2025 967,000.00
Sep 30, 2025 893,000.00
Jun 30, 2025 178,000.00
Mar 31, 2025 93,000.00
Dec 31, 2024 92,000.00
Sep 30, 2024 756,000.00
Jun 30, 2024 6.24 Mn
Mar 31, 2024 9.12 Mn